Analysis of prognostic factors for the antipyretic response to ibuprofen;Análisis de los factores pronósticos de la respuesta antipirética del ibuprofeno

Anales Espanoles de Pediatria

Volumn 53, Issue 5, 2000, Pages 431-435

  Martinon Sanchez F ^a   Antelo Cortizas, J ^b   Morales Redondo, R ^c   Moreno Carretero, E ^d   Dominguez Granados R ^d  

^a Hospital Nuestra Señora del Cristal   (Spain)

^b HOSPITAL XERAL CÍES   (Spain)

^c HOSPITAL XERAL CALDE   (Spain)

^d Laboratorios Knoll SA   (Spain)

Author keywords

Fever; Ibuprofen; Prognostic factors

Indexed keywords

ANALGESIC AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE; ARTICLE; BODY TEMPERATURE; CHILD; COMPARATIVE STUDY; FEMALE; FEVER; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PROGNOSIS; SEX DIFFERENCE; TIME;

AGE FACTORS; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY TEMPERATURE; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; IBUPROFEN; INFANT; MALE; PROGNOSIS; SEX FACTORS; TIME FACTORS;

EID: 0034330184     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Adams SS, McCullogh KF, Nicholson JS. The pharmacological properties of ibuprofen, an antiinflammatory, analgesic and antipyretic agent. Ach Im Pharmacodynam 1969; 178: 115-129.
2. Brooks CD, Schagel CA, Sekhar NC, Sobota JT. Tolerance and pharmacology of ibuprofen. Curr Ther Res 1973; 15: 180-190.
3. Kotob AA. A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia J Int Med Res 1985; 39:140-143.
4. Amdekar YK, Desai RZ. Antipyretic activity of ibuprofen and paracetamol in children with pyrexia. Br J Clin Pract 1985; 39: 140-143.
5. Wilson G, Guerra AJMS, Santos NT. Comparative study of the antipyretic effect of ibuprofen (oral suspension) and paracetamol (suppositories) in paediatrics. J Int Med Res 1984; 12: 250-254.
6. Sheth UK, Gupta K, Paul T, Pispati PK. Measurement of antipyretic activity of ibuprofen and paracetamol in children. J Clin Pahmacol 1980; 20: 672-675.
7. Díez Domingo J, Planelles MV, Baldó JM, Ballester A, Núñez F, Jubert A, Domínguez-Granados R. Ibuprofen prophylaxis for adverse reactions to diphtheria-tetanus-pertussis vaccination: A randomized trial. Curr Ther Res 1998; 59: 579-588.
8. Mäkelä AL, Lempiäiner M, Yrjäna T. Ibuprofen in the treatment of juvenile rheumatoid arthritis: metabolism and concentrations in synovial fluid. Br J Clin Pract 1980; (Supl 6): 23-27.
9. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA 1995; 273: 929-933.
10. Kauffman RE, Fox B, Gupta N. Ibuprofen antipyresis and pharmacokinetics in children. Clin Pharm Ther 1989; 45: 139.
11. Kandoth PW, Joshi MK, Satoskar RS. Compative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. J Int Med Res 1984; 12: 292-297.
12. Gaitonde BB, Dattani K, Morwani K. Antipyretic activity of ibuprofen. J Assoc Phys India 1973; 21: 579.
13. a ed. Londres, 1996; 50-51.
14. Aksoylar S, Aksit S, Caglayan S, Yaprak I, Bakiler R, Cetin F. Evaluation of sponging and antipyretic medication to reduce body temperature in febrile children. Acta Paediatr Jpn 1997; 39(2): 215-217.
15. Díez Domingo J, Ballester Sanz A. Utilización secuencial de antitérmicos. ¿Basado en la evidencia o en la costumbre? An Esp Pediatr 1999; 50: 105-106.